Propofol + Granisetron vs. Propofol + Metoclopramide in Symptom Management of Acute Migraine Headache; a Double-Blind Randomized Clinical Trial

Introduction: Acute headache is one of the most common reasons for emergency department (ED) visits. This study aimed to compare the combination of propofol and granisetron with propofol and metoclopramide in symptom management of acute migraine headache. Methods: In this double-blind randomized...

Full description

Bibliographic Details
Main Authors: Samaneh Abiri, Mehdi Chegin, Reza Soleimani, Naser Hatami, Navid Kalani, Esmail Rayatdoost
Format: Article
Language:English
Published: Shahid Beheshti University of Medical Sciences 2022-03-01
Series:Archives of Academic Emergency Medicine
Subjects:
Online Access:https://journals.sbmu.ac.ir/aaem/index.php/AAEM/article/view/1561
_version_ 1819119076311564288
author Samaneh Abiri
Mehdi Chegin
Reza Soleimani
Naser Hatami
Navid Kalani
Esmail Rayatdoost
author_facet Samaneh Abiri
Mehdi Chegin
Reza Soleimani
Naser Hatami
Navid Kalani
Esmail Rayatdoost
author_sort Samaneh Abiri
collection DOAJ
description Introduction: Acute headache is one of the most common reasons for emergency department (ED) visits. This study aimed to compare the combination of propofol and granisetron with propofol and metoclopramide in symptom management of acute migraine headache. Methods: In this double-blind randomized clinical trial, 60 adult patients with acute migraine headache who referred to ED were randomly divided into two groups of propofol + metoclopramide and propofol + granisetron. Pain and nausea/vomiting severity as well as blood pressure were compared between groups 30, 45, and 60 minutes after treatment. Results: The two groups had similar situation regarding mean age (p = 0.606), sex distribution (p = 0.793), baseline severity of pain (p = 0.642), frequency of nausea/vomiting (p = 0.488), and vital signs (p > 0.05). The severity of pain was similar in the two groups 30 (p = 0.731), 45 (p = 0.460), and 60 (p = 0.712) minutes after treatment. The number of patients with resistant nausea and vomiting 60 minutes after treatment was significantly higher in metoclopramide group (30.0% versus 10.0%; p = 0.033). Diastolic pressure 60 minutes after treatment (81.43 ±8.94 vs. 74.97 ± 4.8; p = 0.001) and heart rate 30 minutes after treatment (68.87 ±6.52 vs. 73.57± 7.62; p = 0.013) had statistically significant differences between the groups. Conclusion: The combination of propofol and granisetron was superior to propofol and metoclopramide in case of controlling nausea and vomiting of cases with acute migraine headache; meanwhile, no differences were observed in case of pain relief and hemodynamic status between the two groups.
first_indexed 2024-12-22T05:59:01Z
format Article
id doaj.art-6f2afffaf96d42f68135c481ae4c271d
institution Directory Open Access Journal
issn 2645-4904
language English
last_indexed 2024-12-22T05:59:01Z
publishDate 2022-03-01
publisher Shahid Beheshti University of Medical Sciences
record_format Article
series Archives of Academic Emergency Medicine
spelling doaj.art-6f2afffaf96d42f68135c481ae4c271d2022-12-21T18:36:36ZengShahid Beheshti University of Medical SciencesArchives of Academic Emergency Medicine2645-49042022-03-0110110.22037/aaem.v10i1.1561Propofol + Granisetron vs. Propofol + Metoclopramide in Symptom Management of Acute Migraine Headache; a Double-Blind Randomized Clinical Trial Samaneh AbiriMehdi CheginReza SoleimaniNaser HatamiNavid Kalani0Esmail Rayatdoostdepartment of anesthesiology Introduction: Acute headache is one of the most common reasons for emergency department (ED) visits. This study aimed to compare the combination of propofol and granisetron with propofol and metoclopramide in symptom management of acute migraine headache. Methods: In this double-blind randomized clinical trial, 60 adult patients with acute migraine headache who referred to ED were randomly divided into two groups of propofol + metoclopramide and propofol + granisetron. Pain and nausea/vomiting severity as well as blood pressure were compared between groups 30, 45, and 60 minutes after treatment. Results: The two groups had similar situation regarding mean age (p = 0.606), sex distribution (p = 0.793), baseline severity of pain (p = 0.642), frequency of nausea/vomiting (p = 0.488), and vital signs (p > 0.05). The severity of pain was similar in the two groups 30 (p = 0.731), 45 (p = 0.460), and 60 (p = 0.712) minutes after treatment. The number of patients with resistant nausea and vomiting 60 minutes after treatment was significantly higher in metoclopramide group (30.0% versus 10.0%; p = 0.033). Diastolic pressure 60 minutes after treatment (81.43 ±8.94 vs. 74.97 ± 4.8; p = 0.001) and heart rate 30 minutes after treatment (68.87 ±6.52 vs. 73.57± 7.62; p = 0.013) had statistically significant differences between the groups. Conclusion: The combination of propofol and granisetron was superior to propofol and metoclopramide in case of controlling nausea and vomiting of cases with acute migraine headache; meanwhile, no differences were observed in case of pain relief and hemodynamic status between the two groups. https://journals.sbmu.ac.ir/aaem/index.php/AAEM/article/view/1561Propofolgranisetronmetoclopramidemigraine disorders
spellingShingle Samaneh Abiri
Mehdi Chegin
Reza Soleimani
Naser Hatami
Navid Kalani
Esmail Rayatdoost
Propofol + Granisetron vs. Propofol + Metoclopramide in Symptom Management of Acute Migraine Headache; a Double-Blind Randomized Clinical Trial
Archives of Academic Emergency Medicine
Propofol
granisetron
metoclopramide
migraine disorders
title Propofol + Granisetron vs. Propofol + Metoclopramide in Symptom Management of Acute Migraine Headache; a Double-Blind Randomized Clinical Trial
title_full Propofol + Granisetron vs. Propofol + Metoclopramide in Symptom Management of Acute Migraine Headache; a Double-Blind Randomized Clinical Trial
title_fullStr Propofol + Granisetron vs. Propofol + Metoclopramide in Symptom Management of Acute Migraine Headache; a Double-Blind Randomized Clinical Trial
title_full_unstemmed Propofol + Granisetron vs. Propofol + Metoclopramide in Symptom Management of Acute Migraine Headache; a Double-Blind Randomized Clinical Trial
title_short Propofol + Granisetron vs. Propofol + Metoclopramide in Symptom Management of Acute Migraine Headache; a Double-Blind Randomized Clinical Trial
title_sort propofol granisetron vs propofol metoclopramide in symptom management of acute migraine headache a double blind randomized clinical trial
topic Propofol
granisetron
metoclopramide
migraine disorders
url https://journals.sbmu.ac.ir/aaem/index.php/AAEM/article/view/1561
work_keys_str_mv AT samanehabiri propofolgranisetronvspropofolmetoclopramideinsymptommanagementofacutemigraineheadacheadoubleblindrandomizedclinicaltrial
AT mehdichegin propofolgranisetronvspropofolmetoclopramideinsymptommanagementofacutemigraineheadacheadoubleblindrandomizedclinicaltrial
AT rezasoleimani propofolgranisetronvspropofolmetoclopramideinsymptommanagementofacutemigraineheadacheadoubleblindrandomizedclinicaltrial
AT naserhatami propofolgranisetronvspropofolmetoclopramideinsymptommanagementofacutemigraineheadacheadoubleblindrandomizedclinicaltrial
AT navidkalani propofolgranisetronvspropofolmetoclopramideinsymptommanagementofacutemigraineheadacheadoubleblindrandomizedclinicaltrial
AT esmailrayatdoost propofolgranisetronvspropofolmetoclopramideinsymptommanagementofacutemigraineheadacheadoubleblindrandomizedclinicaltrial